Matches in Nanopublications for { ?s ?p "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP321294.RAST-UXPvYVaSAYeDfx6V76x89TgVxGPtJr052Ki6FWRA130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321294.RAST-UXPvYVaSAYeDfx6V76x89TgVxGPtJr052Ki6FWRA130_provenance.
- NP321292.RAmBN_CayMsfl2JIGw1LKwk3o83KTta3ztEBPKfO84_ZE130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321292.RAmBN_CayMsfl2JIGw1LKwk3o83KTta3ztEBPKfO84_ZE130_provenance.
- NP321296.RAoj7E2uaLjcnbYezk0bpYiHMAEBS9CZFhOIYOTDnOBns130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321296.RAoj7E2uaLjcnbYezk0bpYiHMAEBS9CZFhOIYOTDnOBns130_provenance.
- NP573137.RA0K2f3jYbCBfsHBrNhXRIqm9JTvM6w1NYCVIrN71r3oU130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573137.RA0K2f3jYbCBfsHBrNhXRIqm9JTvM6w1NYCVIrN71r3oU130_provenance.
- NP573695.RA5mqsb3ga6ZupYUssnQHYj0m8ciWEPOxoVdIh-eNCMb0130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573695.RA5mqsb3ga6ZupYUssnQHYj0m8ciWEPOxoVdIh-eNCMb0130_provenance.
- NP573460.RAKpLGKuxfaYdIFZWDfs1rVl7Tfnw0wky6ILJV3BjYEQE130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573460.RAKpLGKuxfaYdIFZWDfs1rVl7Tfnw0wky6ILJV3BjYEQE130_provenance.
- NP321293.RAMzsaZVFV8SCzw8FDg2P2A150GrcwGBXEa2GUx2GM3fY130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321293.RAMzsaZVFV8SCzw8FDg2P2A150GrcwGBXEa2GUx2GM3fY130_provenance.
- NP321291.RAxDHCbnslHSvro5yQU1jkHdjkPNW1lw1GDx78Dy3sw9c130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321291.RAxDHCbnslHSvro5yQU1jkHdjkPNW1lw1GDx78Dy3sw9c130_provenance.
- NP321295.RAxed_hD2SwzxsXcdZZj7fhRf4hzl6GRNcHG6DOhGxppw130_assertion description "[NS398 decreased cell viability in 2 cyclo-oxygenase-2-positive (COX-2(+)) esophageal cancer cell lines but not in a COX-2(-) cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321295.RAxed_hD2SwzxsXcdZZj7fhRf4hzl6GRNcHG6DOhGxppw130_provenance.